Vizuri catalyses growth and innovation in Africa’s pharmaceutical manufacturing.

With the rapidly changing health and economic landscape in Africa, the stage is set for accelerated investment and growth of the continent’s pharmaceutical manufacturing sector, especially in crucially needed therapeutics and API manufacturing. Vizuri is the platform to catalyse these investments and build the sector’s capabilities in (1) security of supply; (2) quality of commodities; and (3) value.

Whether you’re a donor partner, purchaser, manufacturer or regulator, Vizuri is here to support your needs.

Click on the partner group of your interest to find out more:

Make

Vizuri understands the challenges that hinder sustainable growth of many African pharmaceutical manufacturers.
Vizuri brings together experts with decades of experience in the pharmaceutical and broader life sciences and healthcare industry. Collectively, they address market failures caused by financial constraints, technical capacity, regulatory issues, and demand or supply constraints that limit the ability of African pharmaceutical manufacturers in accelerating their growth.
Vizuri provides technical support and assistance with market research, business case development, fund-raising, licensing, brand development and regulatory advice to enable manufacturers to secure new capital, enter new markets, and expand their range of products.

Vizuri’s team includes many experts who have worked in the African pharmaceutical industry, innovative pharmaceutical, and broader life sciences / healthcare space for decades.
The challenges facing manufacturers of innovative pharmaceutical products in new markets across Africa range from regulatory approval, to demand generation, route-to-market, and licensing.
Vizuri works with IP holders to enter new markets by transferring licenses and dossiers to local manufacturers and / or developing second brand products in partnership with local manufacturers.
Vizuri also taps into its team of subject matter experts and broader networks to provide regulatory support, demand generation advice, and route-to-market assistance to enable IP holders realise market opportunities.

Achieving and maintaining third party quality standards for medicines is not easy and takes time, capital and expertise. This has led to many licensed products being issued to the same small number of manufacturers, which has limited the access to critical innovative and originator brand medicines on the African continent.
Vizuri has the expertise to build the capacity of African pharmaceutical manufacturers to meet these high-quality standards so that transfer enablers have more options, thus building a more competitive, higher quality pharmaceutical market.

Buy

In order to ensure Africa’s supply and availability of quality, affordable medicines for patients across the continent, Vizuri believes in building a resilient and sustainable African pharmaceutical industry.
This involves building the capacity and scale of African pharmaceutical manufacturers to not only capitalise on local demand, but also to make a meaningful contribution to the global market.
Across the continent, Vizuri is able to provide technical support and assistance in route-to-market, demand generation, innovation and technology as well as licensing and regulation, that will enable African pharmaceutical manufacturers to accelerate their growth.
By bringing together industry experts with decades of experience, Vizuri is able to address market failures for manufacturers, and thus support the building of resilient health systems, which are patient-centric, and demand driven.

Having worked on the continent for many decades, Vizuri’s experts understand that procurement processes are fragmented, contributing significantly to high costs of drugs and a limited supply or availability of medicines.
Vizuri is uniquely placed as the only non-profit organisation that has the broad partnerships and expertise to aggregate demand across the African pharmaceutical manufacturing sector in order to drive lower prices and create a more secure supply of commodities.
As an African organisation created to foster a competitive African pharmaceutical manufacturing sector, Vizuri’s focus is on developing an efficient pharmaceutical value chain, and prioritising results-based operating models that are patient-centric and demand driven.

Vizuri is an African organisation created to foster a resilient and sustainable African pharmaceutical manufacturing sector.
Having worked on the continent for many decades, Vizuri’s experts understand that procurement processes are fragmented, contributing significantly to high costs of drugs and a limited supply or availability of medicines.
Vizuri is uniquely placed as the only non-profit organisation that has the broad partnerships and expertise to aggregate demand across the African pharmaceutical manufacturing sector to drive lower prices and create a more secure supply of commodities.
Vizuri knows that creating an African solution that solves for the changing health needs of the continent is imperative. Building the capacity and scale of Africa’s pharmaceutical manufacturing sector will not only improve the quality, accessibility and availability of medicines, but it will also enable the sector itself to generate capital and jobs, and ultimately develop more resilient health systems and healthier populations.

Fund

Africa’s population is the fastest growing in the world. Projected demand for medicines will inevitably increase, yet today, Africa produces less than 5% of the medicines it currently needs.
Creating an African solution that solves for the changing health needs of the continent is imperative and the benefits are unparalleled.
As an African organisation, Vizuri was created to foster a sustainable African pharmaceutical manufacturing sector to ensure Africa’s supply and availability of quality, affordable medicines for patients across the continent.
Based on established partnerships across the public and private sectors in all four regions of the continent, Vizuri brings together experts in the industry to build the capacity and scale of Africa’s pharmaceutical manufacturers.
Vizuri will focus on crucially needed therapeutics and API manufacturing and will deliver on three market fundamentals to enable the sector: (1) security of supply; (2) quality of commodities; and (3) value.
By building a resilient and sustainable African pharmaceutical manufacturing sector, not only will the quality, accessibility and availability of medicines be improved, but the sector itself will generate capital and jobs, and ultimately create more resilient health systems and healthier populations.

Vizuri comprises experts and advisors who have been in the African pharmaceutical (and broader life sciences and healthcare) industry for decades. Vizuri has a deep understanding of the investment opportunities and financial challenges facing lenders and borrowers in Africa’s health landscape.
Vizuri’s vision of a sustainable partnership dedicated to building a resilient African pharmaceutical industry requires long term commitment and foresight.
Vizuri offers technical support to navigate local market conditions, as well as ‘fit-for-purpose’ financial assistance to structure bespoke financial mechanisms that enable long-term interventions which yield results and returns.
By managing the full breadth of risk factors, from quality to financial and reputational, Vizuri ensures value for money for all stakeholders. The result is a sustainable and competitive African pharmaceutical manufacturing sector that provides quality, accessible and available medicines and ultimately a more resilient health system and healthier populations.

Vizuri comprises experts and advisors who have been in the African pharmaceutical industry for decades. Vizuri has a deep understanding of the investment opportunities and financial challenges facing lenders and borrowers in Africa’s health landscape.
Vizuri’s vision of a sustainable partnership dedicated to building a resilient African pharmaceutical industry requires long term commitment and foresight.
Vizuri offers technical support to navigate local market conditions, as well as ‘fit-for-purpose’ financial assistance to structure bespoke financial mechanisms that enable long-term interventions which yield results and returns.
Coupled with Vizuri’s subject matter experts that provide technical assistance to African pharmaceutical manufacturers, Vizuri can create an efficient pharmaceutical value chain.
By managing the full breadth of risk factors, from quality to financial and reputational, Vizuri ensures value for money for all stakeholders.

Regulate

Africa’s population is one of the fastest growing in the world. Projected demand for medicines will inevitably increase, yet today, Africa produces less than 5% of the medicines it currently needs.
Creating an African solution that solves for the changing health needs of the continent is imperative and the benefits are unparalleled.
Vizuri is an African organisation created to foster a sustainable African pharmaceutical manufacturing sector to ensure Africa’s supply and availability of quality, affordable medicines for patients across the continent.
By building a resilient and sustainable African pharmaceutical manufacturing sector, not only will the quality, accessibility and availability of medicines be improved, but the sector itself will generate capital and jobs, and ultimately create more resilient health systems and healthier populations.
Regulatory stakeholders play a critical role in building a resilient and sustainable African pharmaceutical manufacturing sector. Vizuri will work in partnership with regulators to:
- Enable manufacturers to supply quality products by providing them with technical assistance to manufacture regulation approved products;
- Ensure manufacturers are producing these quality products and providing assurances for them; and
- Address regulatory, trade and non-trade barriers that prevent the development and growth of the African manufacturing sector and a stable supply of quality assured products.
Vizuri’s engagement with regulators will be based on the needs of manufacturing partners, or a set of prioritised products, to ensure that these products are produced at all the required quality assurance standards.

Africa’s population is one of the fastest growing in the world. Projected demand for medicines will inevitably increase, yet today, Africa produces less than 5% of the medicines it currently needs.

Creating an African solution that solves for the changing health needs of the continent is imperative and the benefits are unparalleled.
Vizuri is an African organisation created to foster a sustainable African pharmaceutical manufacturing sector to ensure Africa’s supply and availability of quality, affordable medicines for patients across the continent.
By building a resilient and sustainable African pharmaceutical manufacturing sector, not only will the quality, accessibility and availability of medicines be improved, but the sector itself will generate capital and jobs, and ultimately create more resilient health systems and healthier populations.
Regulatory stakeholders play a critical role in building a resilient and sustainable African pharmaceutical manufacturing sector. Vizuri will work in partnership with regulators to:
- Enable manufacturers to supply quality products by providing them with technical assistance to manufacture regulation approved products;
- Ensure manufacturers are producing these quality products and providing assurances for them; and
- Address regulatory, trade and non-trade barriers that prevent the development and growth of the African manufacturing sector and a stable supply of quality assured products.
Vizuri’s engagement with regulators will be based on the needs of manufacturing partners, or a set of prioritised products, to ensure that these products are produced at all the required quality assurance standards.

Other

Africa’s population is one of the fastest growing in the world. Projected demand for medicines will inevitably increase, yet today, Africa produces less than 5% of the medicines it currently needs.
Creating an African solution that solves for the changing health needs of the continent is imperative and the benefits are unparalleled.
Vizuri is an African organisation created to foster a sustainable African pharmaceutical manufacturing sector to ensure Africa’s supply and availability of quality, affordable medicines for patients across the continent.
By building a resilient and sustainable African pharmaceutical manufacturing sector, not only will the quality, accessibility and availability of medicines be improved, but the sector itself will generate capital and jobs, and ultimately create more resilient health systems and healthier populations.
Patient advocacy groups, and consumer and profession groups, play a critical role in building a resilient and sustainable African pharmaceutical manufacturing sector. Vizuri will work in partnership with these stakeholders to address manufacturing partners’ needs in order to support their growth and development.

Africa’s population is one of the fastest growing in the world. Projected demand for medicines will inevitably increase, yet today, Africa produces less than 5% of the medicines it currently needs.
Creating an African solution that solves for the changing health needs of the continent is imperative and the benefits are unparalleled.
Vizuri is an African organisation created to foster a sustainable African pharmaceutical manufacturing sector to ensure Africa’s supply and availability of quality, affordable medicines for patients across the continent.
By building a resilient and sustainable African pharmaceutical manufacturing sector, not only will the quality, accessibility and availability of medicines be improved, but the sector itself will generate capital and jobs, and ultimately create more resilient health systems and healthier populations.
Academic research institutions and key opinion leaders play a critical role in building a resilient and sustainable African pharmaceutical manufacturing sector. Vizuri will work in partnership with these stakeholders to address manufacturing partners’ needs in order to support their growth and development.

Join us in creating a thriving African pharmaceutical manufacturing sector.